Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | H196 - AI as a Tool in Academic Neurology: From Black Bags to Black Boxes (Academic Hub)

Wednesday 04/17/24
08:00 AM - 08:45 AM MDT Add To Calendar
Colorado Convention Center | Mile High 1A
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Academic)
Andrew M. Southerland, MD, FAAN
Leadership
Over the past few years, we seem to be inundated with discussion of artificial intelligence (AI) in academic medicine. While feelings range from natural excitedness to healthy trepidation, questions remain about how best we might utilize AI tools in academic practice without eroding the very aspects that we has humans enjoy and indeed do well.  In this session, we will discuss examples of how AI and other machine learning or natural language processing tools can augment the work of the academic neurologist, including examples pertinent to clinical practice, neurologic research, and the educational environment. The session will conclude with audience discussion and Q & A.         
No CME available
Interpersonal and Communication Skills, Practice-based Learning and Improvement, Systems-based Practice
Introductory
Artificial Intelligence
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
08:00 AM - 08:45 AM MDT Speaker AI as a Tool in Academic Neurology: From Black Bags to Black Boxes
Andrew M. Southerland, MD, FAAN
Faculty Disclosures
Andrew M. Southerland, MD, FAAN Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.